Navigation Links
Research team discovers 'immune gene' in Neanderthals
Date:11/22/2013

A research group at Bonn University and international collaborators discovered a novel receptor, which allows the immune system of modern humans to recognize dangerous invaders, and subsequently elicits an immune response. The blueprint for this advantageous structure was in addition identified in the genome of Neanderthals, hinting at its origin. The receptor provided these early humans with immunity against local diseases. The presence of this receptor in Europeans but its absence in early men suggests that it was inherited from Neanderthals. The results have been published in advance online in the Journal of Biological Chemistry. The printed edition is expected in a following issue.

When pathogens infect the human body, the immune system identifies and attacks dangerous invaders. During evolution, an efficient defence system developed, which vaguely resembles methods used by secret agents. With the help of certain genes, the human leukocyte antigen system (HLA) produces receptors that assess the risk rate of the pathogens using their profile which has just eight amino acids. "This function can be compared to a text which is identified by a spy as being suspicious, based on just a few letters of a word," says Prof. Dr. Norbert Koch from the Institute for Genetics, Department of Immunobiology at the University of Bonn.

Immune System Scans the Amino Acids of the Pathogens

In order to decipher this message, the immune system breaks down the invaders proteins into peptides and subsequently scans a proportion of the peptides for their amino acid sequences. Up until now, a total of three different peptide receptors of more than 1000 different manifestations were known, which in humans can read the telltale letter combinations. "This variety is needed so that the immune system can rate the entire spectrum of pathogens relevant for humans," explains Prof. Koch. A fourth receptor, or another "spy", has now been found by an international team of scientists from the University of Dsseldorf, the Technical University of Munich, Jacobs University Bremen and Cambridge University under the leadership of the immunobiologists at the University of Bonn.

This receptor, which is abbreviated as "HLA-DRaDPb", consists of the combination of subunits of already known receptors. Scientists compared the gene sequence, which encodes the discovered receptor, with data bases and determined that an estimated two-thirds of Europeans carry this important structure. Even Prof. Koch carries the blueprint for this "spy", as one of his students found out by sequencing his DNA. Scientists were nonetheless surprised to learn that the gene sequence required for this receptor is rare in people in southern Africa, the region known as the cradle of mankind. "When early man, the ancestor of today's humans, left Africa and migrated a few hundred thousand years ago to Europe, he did not yet have this receptor," says Prof. Koch.

Modern Man Owes Receptor to Neanderthals

Prof. Dr. Svante Pbo from the Max Planck Institute for Evolutionary Anthropology in Leipzig played a leading role in 2010 in sequencing and presenting the Neanderthal genome. So, scientists examined whether Neanderthals as an example of early men had the key gene sequence which contains the blueprint for the receptor. Dr. Sebastian Temme, who conducted a major part of the experimental work, compiled, together with colleagues from Dsseldorf, the sequence of the Neanderthal genome, from small fragments obtained from the Neanderthal data base. "The identified Neanderthal gene sequence is almost identical with that of modern humans," concludes Prof. Koch.

Neanderthals probably lived many hundreds of thousands of years in Europe during which time they developed the HLA receptor that provided them with immunity against many pathogens. This means that different to our ancestors from Africa, the Neanderthals which were resident in Europe, carried this receptor on their immune cells. That was a distinct evolutionary advantage," says the immunobiologist from the University of Bonn, who presumes that we modern humans in Europe owe this advantageous receptor to the Neanderthals.


'/>"/>

Contact: Dr. Norbert Koch
norbert.koch@uni-bonn.de
49-228-734-343
University of Bonn
Source:Eurekalert  

Related biology news :

1. LSUHSC research finds combo of plant nutrients kills breast cancer cells
2. UCLA, Emory researchers find a chemical signature for fast form of Parkinsons
3. Wonder of Nanotechnology details research enabling nanoscale optoelectronic devices
4. Researchers map brain areas vital to understanding language
5. MU research sheds light on nerve regeneration following spinal cord injury
6. Researchers gain fuller picture of cell protein reactions
7. Scripps oceanography researchers engineer breakthrough for biofuel production
8. USF researchers show invasive sparrows immune cells sharpen as they spread
9. Researchers use CT and 3-D printers to recreate dinosaur fossils
10. Natural compound mitigates effects of methamphetamine abuse, University of Missouri researchers find
11. Researchers classify urban residential desert landscapes
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Research team discovers 'immune gene' in Neanderthals
(Date:4/13/2016)... , April 13, 2016  IMPOWER physicians supporting Medicaid ... setting a new clinical standard in telehealth thanks to ... leveraging the higi platform, IMPOWER patients can routinely track ... and body mass index, and, when they opt in, ... convenient visit to a local retail location at no ...
(Date:3/31/2016)... -- Genomics firm Nabsys has completed a financial  restructuring under ... M.D., who returned to the company in October 2015. ... including Chief Technology Officer, John Oliver , Ph.D., ... Vice President of Software and Informatics, Michael Kaiser ... Bready served as CEO of Nabsys from 2005-2014 and ...
(Date:3/23/2016)... , March 23, 2016 ... erhöhter Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender ... das Unternehmen mit SpeechPro zusammenarbeitet, um erstmals ... Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, im Rahmen ...
Breaking Biology News(10 mins):
(Date:4/27/2016)... ... , ... Global Stem Cells Group CEO Benito Novas announced that ... GSCG affiliate Kimera Labs in Miami. , In 2004, Ross received his Ph.D. in ... hematologic disorders and the suppression of graft vs. host disease (GVHD) under UM Professor ...
(Date:4/26/2016)... , ... April 26, 2016 , ... ... announced that Ardy Arianpour has joined the company as Chief Business Officer. Arianpour, ... bringing innovative genomic technologies to market, was most recently Chief Commercial Officer of ...
(Date:4/26/2016)... ... April 26, 2016 , ... BioFactura, Inc ., ... A round of financing. Healthy investor interest drove significant oversubscription of the original ... biologics, known as biosimilars, to the advanced preclinical stages. , Chief Executive Officer and ...
(Date:4/26/2016)... 26, 2016 genae, a Contract ... industries, announced today the appointment of Prof. Dr. Jörn ... Balzer,s responsibilities will include all clinical, safety and risk ... feel privileged and honored with the acceptance of Prof. ... , CEO at genae. "Prof. Balzer,s impressive and extensive ...
Breaking Biology Technology: